Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitronazine tablets for diabetic kidney disease (phase II)
CTR20192413Phase 2Completed
- Sponsor
- Guangzhou Magpie Pharmaceutical
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitronazine in diabetic glomerulosclerosis, sponsored by Guangzhou Magpie Pharmaceutical. Started May 2020; status: completed.
02
Drugs
nitronazine
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on CTR20192413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192413.